XLABS Therapeutics

XLABS Therapeutics is a biotechnology company focused on the discovery and development of novel therapeutic candidates using an integrated drug discovery platform. The company leverages advanced computational tools and high-throughput screening to identify small molecules and biologics targeting high-value pathways in oncology and immunology. By combining structural biology with machine learning, XLABS aims to accelerate the transition from target identification to clinical candidate selection. Their current pipeline consists of several early-stage programs designed to address unmet medical needs in complex disease areas.